18 Stocks Moving in Thursday’s Pre-Market Session
Gainers
Calliditas Therapeutics AB (NASDAQ: CALT) rose 36.5% to $25.45 in pre-market trading after the company announced it was granted by the FDA accelerated approval of TARPEYO to reduce proteinuria in lgA nephropathy.
Cannabis Movers & Shakers: NORML, TGOD, Enveric Biosciences, Dalwhinnie Enterprises
Texas NORML Director Hired To Oversee State Policy Reform Efforts
The National Organization for the Reform of Marijuana Laws (NORML) recently announced that it has tapped Jax Finkel James to its national staff.
Enveric Biosciences’ CBD-Based Product Reduces Dermatitis Severity In Animal Study
Enveric Biosciences (NASDAQ:ENVB) announced data from a preclinical rodent model evaluating EV102, the company’s cannabidiol (CBD) based product in development for…
Enveric Biosciences Reports Preclinical Data For EV102 Radiodermatitis Drug Candidate: Showed Reduction In Severity Of Dermatitis
- Significant Reduction in Dermatitis Severity Demonstrated
NAPLES, Fla., Nov. 18, 2021 /PRNewswire/ - Enveric Biosciences (NASDAQ: ENVB) ("Enveric" or the "Company"), a
Earnings Scheduled For November 16, 2021
Companies Reporting Before The Bell
• Ozon Holdings (NASDAQ:OZON) is expected to report quarterly loss at $0.90 per share on revenue of $602.00 million.
There Are Now 50 Psychedelics Companies Listed In The U.S. – Here They Are
Just two years ago, the psychedelics sector was a small research space reserved for academics and extremely forward-thinking investors.
Bringing Mental Health Pharmacology into the 21st Century: How the Marriage of Enveric Biosciences and MagicMed Industries Could Revolutionize the Way We Treat Mental Health
Photo by Christina Victoria Craft on Unsplash